Filters

by ProSci

Showing 25 of 58 items meeting your criteria.

Type	Category	Supplier

Does Your Research Require High-Quality and Consistent Rabbit Recombinant Antibodies? ProSci offers a comprehensive suite of services for recombinant antibody development, including antigen design and antibody purification and production. Their expert team uses advanced tools and technologies to develop rabbit recombinant antibodies with a defined structure, providing highly consistent and specific antibodies.
Documents	Service	ProSci	View
Enhance your Research with ProScis Polyclonal Antibody Services ProSci offers Polyclonal Antibody Services in various custom configurations and standard packages, from Antigen Design and Synthesis to Immunisation to Production.
Documents	Service	ProSci	View
The Role of Monoclonal Antibodies and Biosimilars in Research With more than 800 research-grade biosimilar antibodies in ProScis catalogue, these unique tools are available for researchers worldwide. Complimenting ProScis catalogue is a team of custom antibody specialists that provide researchers with expertise in the design, development, purification, and production of antibodies.
Documents	Service	ProSci	View
Rabbit Monoclonal Antibody Development Flyer Recombinant rabbit monoclonal antibodies are excellent tools for challenging targets such as small molecules or post-translational modifications. ProSci offers customisable Rabbit Monoclonal Antibody Development Packages.
Documents	Antibodies	ProSci	View
Single Domain Antibody Development Flyer The Single Doman Antibody (sdAb) from camelids, also known as VHH antibodies, provides cutting-edge antibody technology. ProSci offers customisable Single Domain Antibody Development Packages.
Documents	Antibodies	ProSci	View
Polyclonal Antibody Development Services Flyer The Polyclonal Antibody, available from a wide variety of host animals, is a widely used research and diagnostic tool. ProSci offers a custom polyclonal antibody development service.
Documents	Service	ProSci	View
Apoptosis vs Necroptosis Infographic Apoptosis and necroptosis are types of programmed cell death (PCD) that are characterised by distinct features and functions. Understanding these differences is important to develop effective treatment approaches for cancer and other diseases.
Documents	Apoptosis	ProSci	View
Insights into the Molecular Mechanisms Regulating Necroptosis Necroptosis, a form of regulated cell death, has gained significant attention recently due to its involvement in various physiological and pathological processes. Necroptosis is a specialized form of programmed cell death that is tightly controlled by various signaling pathways, mediators, and immune responses. Interferon-γ (IFN-γ) and Toll-like receptor 4 (TLR4) signaling pathways have been identified as critical regulators of necroptosis in macrophages. Understanding the underlying molecular mechanisms that govern necroptosis is essential for unraveling its role in immune responses and disease pathogenesis.
Documents	Antibodies	ProSci	View
Single Domain Antibody Development Services ProSci offers single domain antibody development services. ProSci has 25+ years of developing antibodies, developed 20,000+ custom antibodies, and offers customisable services tailored to specific needs.
Documents	Antibodies	ProSci	View
Single Domain Antibodies Brochure The Single Doman Antibody (sdAb) from camelid, also known as VHH antibodies, provides cutting edge technology for antibody research. sdAbs lack light chains and are smaller and more stable than conventional antibodies, yet they possess fully functional antigen-binding capability. Due to its size (a mere 15 kDa), a single domain antibody is adept at reaching otherwise inaccessible epitopes.
Documents	Antibodies	ProSci	View
SARS-CoV-2 Pseudoviruses ProSci has developed SARS-CoV-2 pseudoviruses with a luciferase reporter allowing researchers to quickly build their own neutralization and inhibitor interaction assays. These pseudoviruses have been engineered to lack the appropriate coding for the virus to replicate.
Documents	COVID-19	ProSci	View
Single Domain Antibodies the Next Generation of Recombinant Antibodies Single domain antibodies (sdAbs) are small antigen-binding fragments with unique characteristics that make them useful alternatives to conventional antibodies and important tools in research, diagnostics and therapeutics.
Documents	Antibodies	ProSci	View
SARS-CoV-2 Open Reading Frames (ORFs) The SARS-CoV-2 virus which causes COVID-19 is comprised of 10 open reading frames (ORFs). Many of these create structural proteins and nonstructural proteins, but several of them generate unique proteins named after the ORF they are encoded by. Inhibiting some of these SARS-CoV-2 proteins which contribute to viral immune evasion could lead to faster clearing of SARS-CoV-2 infection by improving the hosts antiviral systems. ProScis catalogue has antibodies and recombinant proteins to many of the SARS-CoV-2 ORF accessory proteins.
Documents	COVID-19	ProSci	View
ProSci PD-1 Antibodies White Paper There has been significant interest in the role of programmed cell death protein 1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) in modulating immune responses. The emergence of PD-1-targeted therapies has revolutionized cancer treatment, leading to a better understanding of immune checkpoint mechanisms and their uses in various research fields. This paper offers a review of significant publications on the use of PD-1 antibodies in cancer, immunology, and Alzheimers disease research. We will highlight the importance of PD-1 antibodies in resolving the complicated interactions between the immune system and pathological conditions as well as their potential to create novel therapeutic approaches.
Documents	Antibodies	ProSci	View
Research Grade Biosimilars Antibodies developed as therapeutics have proven to be valuable tools in the fight against devastating diseases from cancer and autoimmune disorders, to infectious and neurodegenerative diseases. Listed are antibody drug analogs available to researchers worldwide, including reagents targeting: Cancer, Neurodegeneration, Autoimmunity, Inflammation, and Pain, and Infectious Diseases (products are RUO).
Documents	Antibodies	ProSci	View
Inflammasome Research Reagents from ProSci Inc. Inflammasomes are protein complexes present in the cytosol that activate Caspase 1 (CASP1) leading to induction of pro-inflammatory cytokines and pyroptosis (caspase-1 mediated, inflammatory cell death). Understanding the activation, and in contrast the inhibition of inflammasome triggering events can lead to the development of more effective treatments for disorders and diseases including autoimmune diseases, obesity, and infectious diseases.
Documents	Inflammation	ProSci	View
Polyclonal Antibody Development Services Their unique characteristics give them the capability to bind to multiple epitopes of a single antigen. This makes polyclonal antibodies a flexible and reliable tool for researchers and developers of diagnostic assays. ProSci’s Custom Antibody Services Team has over 24 years’ experience in designing, developing, and purifying polyclonal, monoclonal, and recombinant antibodies.
Documents	Antibodies	ProSci	View
Poxvirus Research Tools Poxviruses are viruses from the Poxviridae family. This family of viruses includes several types of infectious viruses that affect both humans and animals. One of the most recognized viruses in Poxviridae is smallpox which has been mostly eradicated with the use of vaccines, while other strains such as the monkeypox virus have been spreading in countries around the world. Many viruses in the Poxviridae family have genetic similarities which allows many of the same research tools to be used on multiple viral species.
Documents	Virology	ProSci	View
Into the Cytokine Storm ProSci is the leading supplier in antibodies and proteins for cytokine research. Our list includes interferons (IF), interleukins (ILs), tumor necrosis factor (TNF), chemokines, colony stimulating factors (CSFs), and growth factors.
Documents	COVID-19	ProSci	View
Immune Checkpoint Antibodies ProSci Inc. has developed several new classes of reagents that can be used to study the actions of multiple immune checkpoint proteins such as CTLA-4, PD-1, and its ligands PD-L1 and PD-L2. These classes of products included highly validated Risk Free™ mouse monoclonal antibodies (mAbs), llama single domain antibodies, rabbit polyclonal antibodies, as well as recombinant proteins, tissue and cell slides and lysates. These products should prove useful in basic research, diagnostics, and drug development in the field of cancer immunotherapy.
Documents	Immunology	ProSci	View
ProSci Single Domain Antibodies The Single Doman Antibody (sdAb) from camelids, also known as VHH antibodies, provides cutting-edge technology for antibody research. The sdAb lacks light chains and is smaller and more stable than conventional antibodies yet possesses fully functional antigen-binding capability. Due to its size (a mere 15 kDa), a single domain antibody is adept at reaching otherwise inaccessible epitopes. • Smallest functional antibody unit at ~15 kDa • Unique binding capacity to conformational epitopes and active sites • Unique physical properties can lead to increased stability under extreme temerature and pH, as well as increased solubility • Recombinantly produced for lot-to-lot reporducibility • Adaptable through antibody engineering • Products for Immune Checkpoints and SARS_Cov_2 targets.
Documents	Antibodies	ProSci	View
ProSci Influenza Reagents ProSci offers an extensive catalog of influenza research reagents for researchers worldwide. Reagents include influenza A detection sets, influenza matched pair antibodies (for influenza A and B), and more antibodies and recombinant proteins for the different strains of influenza viral antigen. • Extensive catalog of antibodies against diverse Influenza A viruses (IAVs) such as H1, H3, H5, H7, N1, N2, N9, etc. • Antibodies produced in mice, rabbits, and goats against different peptides or recombinant protein with potential for matched pairs • Diverse applications with corresponding validation data • Affordable custom services available, including camelid single domain recombinant services
Documents	Virology	ProSci	View
ProSci SARS-CoV-2 Variant Research Reagents ProSci offers antibodies specific for point mutations in the Spike protein unique to Variants of Concern, including Omicron and Delta. • Target specific point mutations in the Spike protein • Bridge the knowledge gap between RNA analysis and protein expression • Build your own toolbox to investigate SARS-CoV-2 gene expression • Study circulating variants at protein level • Determine viral protein distribution in tissues
Documents	COVID-19	ProSci	View
ProSci COVID-19 Products SARS Cov-2 Antibodies and Recombinant Proteins, and related targets from ProSci-Inc.
Documents	COVID-19	ProSci	View
Immuno-Oncology RISK FREE ANTIBODIES Immuno-Oncology (IO) is now providing novel and exciting targeted cancer treatments. The number of potential immune targets that can be used for immunotherapy continues to grow. ProSci is actively developing antibodies to aid IO research, diagnostics and therapeutic development.
Documents	Immunology	ProSci	View

1 2 3 Next Last Show Max.